Cargando…

New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma

SIMPLE SUMMARY: This study investigated the association between survival outcome and the new grading system among advanced stage lung adenocarcinoma (LADC) (stages IIIA, IIIB and IV) patients who were diagnosed as LADC with a pathologic report according to a new grading system by the International A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Ching-Fu, Huang, Chi-Jung, Huang, Shih-Hung, Wu, Mei-Hsuan, Tseng, Ailun Heather, Sung, Yung-Chuan, Lee, Henry Hsin-Chung, Ling, Thai-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698816/ https://www.ncbi.nlm.nih.gov/pubmed/33218158 http://dx.doi.org/10.3390/cancers12113426

Ejemplares similares

Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426
por: Weng, Ching-Fu, et al.
Publicado: (2021)

Unusual synchronous double primary treatment-naïve lung adenocarcinoma harboring T790M and L858R mutations in early-stage lung cancer
por: Weng, Ching-Fu, et al.
Publicado: (2019)

A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma
por: Wang, Kai, et al.
Publicado: (2023)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

IASLC Textbook of Prevention and Early Detection of Lung Cancer
por: Spiro, S G
Publicado: (2006)

Low-grade fibromyxoid sarcoma of the external anal sphincter: a case report
por: Ban, Lee-Kiat, et al.
Publicado: (2017)

A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system
por: Gao, Zhaoming, et al.
Publicado: (2022)

A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination
por: Bossé, Yohan, et al.
Publicado: (2023)

The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
por: E, Haoran, et al.
Publicado: (2023)

Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays
por: Weng, Ching-Fu, et al.
Publicado: (2020)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
por: Wang, Hongyan, et al.
Publicado: (2018)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

High-grade fetal adenocarcinoma of the lung
por: Cheng, Chiu-Hsuan
Publicado: (2019)

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
por: Sun, Yifeng, et al.
Publicado: (2016)

Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma
por: Lu, Hsuan-Hsuan, et al.
Publicado: (2020)

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
por: Woo, Wongi, et al.
Publicado: (2022)

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
por: Wang, Tengteng, et al.
Publicado: (2017)

A Proposal to Modify the 8th IASLC System: Is it Suitable for T4N2M0 Lung Adenocarcinoma to Be Placed in Stage IIIB?
por: Ruan, Tian, et al.
Publicado: (2022)

Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations
por: Jarabo Sarceda, José Ramón, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification
por: LI, SHUHAI, et al.
Publicado: (2016)

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
por: Zhao, Shilei, et al.
Publicado: (2015)

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
por: Cruz-Rico, Graciela, et al.
Publicado: (2021)

PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
por: Smeltzer, M., et al.
Publicado: (2021)

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations
por: Muñoz-Guglielmetti, Diego, et al.
Publicado: (2021)

Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2022)

Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations
por: Huang, Jinbao, et al.
Publicado: (2019)

Sex Disparities in the Association of Lung Adenocarcinoma with Colorectal Cancer
por: Jian, Zhi-Hong, et al.
Publicado: (2013)

Outcomes of salvage lung resections in advanced EGFR ‐mutant lung adenocarcinomas under EGFR TKIs
por: Chen, Ying‐Yuan, et al.
Publicado: (2021)

EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
por: Tseng, Chien-Hua, et al.
Publicado: (2017)

Ambient Cumulative PM2.5 Exposure and the Risk of Lung Cancer Incidence and Mortality: A Retrospective Cohort Study
por: Huang, Hung-Ling, et al.
Publicado: (2021)

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
por: Huang, Yen-Hsiang, et al.
Publicado: (2022)

The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010
por: Ito, Hiroyuki, et al.
Publicado: (2022)

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

Bletinib ameliorates neutrophilic inflammation and lung injury by inhibiting Src family kinase phosphorylation and activity
por: Kao, Ting‐I, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6b75tmsgokllq5dt0ert2k1h1